Gilbert & Cook Inc. Has $525,000 Holdings in Johnson & Johnson (JNJ)

Gilbert & Cook Inc. cut its position in shares of Johnson & Johnson (NYSE:JNJ) by 45.1% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,040 shares of the company’s stock after selling 3,325 shares during the quarter. Gilbert & Cook Inc.’s holdings in Johnson & Johnson were worth $525,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of JNJ. McKinley Carter Wealth Services Inc. lifted its position in shares of Johnson & Johnson by 14.5% in the third quarter. McKinley Carter Wealth Services Inc. now owns 8,308 shares of the company’s stock worth $1,080,000 after purchasing an additional 1,052 shares in the last quarter. Cidel Asset Management Inc. raised its position in Johnson & Johnson by 3.0% during the third quarter. Cidel Asset Management Inc. now owns 184,431 shares of the company’s stock valued at $23,978,000 after acquiring an additional 5,292 shares in the last quarter. Artemis Investment Management LLP bought a new position in Johnson & Johnson during the third quarter valued at approximately $11,478,000. Berkshire Asset Management LLC PA raised its position in Johnson & Johnson by 0.3% during the third quarter. Berkshire Asset Management LLC PA now owns 199,426 shares of the company’s stock valued at $25,927,000 after acquiring an additional 513 shares in the last quarter. Finally, Perennial Advisors LLC raised its position in Johnson & Johnson by 2.3% during the third quarter. Perennial Advisors LLC now owns 33,884 shares of the company’s stock valued at $4,405,000 after acquiring an additional 759 shares in the last quarter. 65.71% of the stock is owned by institutional investors.

Johnson & Johnson (JNJ) opened at $147.36 on Friday. Johnson & Johnson has a twelve month low of $110.76 and a twelve month high of $148.32. The company has a current ratio of 1.32, a quick ratio of 1.02 and a debt-to-equity ratio of 0.36. The company has a market capitalization of $395,890.00, a P/E ratio of 25.58, a price-to-earnings-growth ratio of 2.75 and a beta of 0.80.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 13th. Shareholders of record on Tuesday, February 27th will be issued a dividend of $0.84 per share. The ex-dividend date is Monday, February 26th. This represents a $3.36 annualized dividend and a yield of 2.28%. Johnson & Johnson’s dividend payout ratio (DPR) is presently 58.33%.

Several equities analysts recently weighed in on the stock. Vetr raised shares of Johnson & Johnson from a “hold” rating to a “buy” rating and set a $150.89 price objective on the stock in a research report on Thursday, January 11th. Stifel Nicolaus raised their price objective on shares of Johnson & Johnson from $140.00 to $142.00 and gave the company a “hold” rating in a research report on Wednesday, October 18th. Citigroup raised their price objective on shares of Johnson & Johnson from $140.00 to $149.00 and gave the company a “buy” rating in a research report on Monday, October 23rd. Jefferies Group raised shares of Johnson & Johnson from a “hold” rating to a “buy” rating and raised their price objective for the company from $145.00 to $157.00 in a research report on Wednesday, October 11th. Finally, Argus raised their price objective on shares of Johnson & Johnson from $145.00 to $165.00 and gave the company a “positive” rating in a research report on Wednesday, October 18th. Four equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and eleven have assigned a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus target price of $145.94.

TRADEMARK VIOLATION WARNING: “Gilbert & Cook Inc. Has $525,000 Holdings in Johnson & Johnson (JNJ)” was published by Sports Perspectives and is the sole property of of Sports Perspectives. If you are accessing this article on another website, it was stolen and republished in violation of US and international trademark & copyright legislation. The correct version of this article can be read at https://sportsperspectives.com/2018/01/21/gilbert-cook-inc-has-525000-holdings-in-johnson-johnson-jnj.html.

Johnson & Johnson Profile

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.

Want to see what other hedge funds are holding JNJ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Johnson & Johnson (NYSE:JNJ).

Institutional Ownership by Quarter for Johnson & Johnson (NYSE:JNJ)

Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply